Development of targeted therapies against tumors with aberrant MAPK signaling.

被引：0
|
作者：
Ebi, Hiromichi [1 ]
机构：
[1] Aichi Canc Ctr Res Inst, Div Mol Therapeut, Nagoya, Aichi, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MVA-2
引用
收藏
页码：1254 / 1254
页数：1
相关论文
共 50 条
  • [41] TARGETED THERAPY FOR MAPK PATHWAY ALTERATIONS IN PEDIATRIC TUMORS
    Suthar, Jugal
    Taylor, Alaric
    Berry, Philip
    Veal, Gareth
    Guldin, Stefan
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S619 - S620
  • [42] Signaling pathways and targeted therapies in Ewing sarcoma
    Jia, Ke
    Cao, Li
    Yu, Yihan
    Jing, Doudou
    Wu, Wei
    Van Tine, Brian Andrew
    Shao, Zengwu
    PHARMACOLOGY & THERAPEUTICS, 2025, 266
  • [43] Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
    Hu, Yuchen
    Peng, Linrui
    Zhuo, Xinyu
    Yang, Chan
    Zhang, Yuwei
    BIOMOLECULES, 2024, 14 (12)
  • [44] Correction: Signaling pathways and targeted therapies for psoriasis
    Jia Guo
    Hanyi Zhang
    Wenrui Lin
    Lixia Lu
    Juan Su
    Xiang Chen
    Signal Transduction and Targeted Therapy, 9
  • [45] MET in glioma: signaling pathways and targeted therapies
    Cheng, Fangling
    Guo, Dongsheng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [46] Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
    Setlai, Botle Precious
    Hull, Rodney
    Bida, Meshack
    Durandt, Chrisna
    Mulaudzi, Thanyani Victor
    Chatziioannou, Aristotelis
    Dlamini, Zodwa
    BIOMEDICINES, 2022, 10 (03)
  • [47] Wnt/β-catenin signaling in cancers and targeted therapies
    Fanyuan Yu
    Changhao Yu
    Feifei Li
    Yanqin Zuo
    Yitian Wang
    Lin Yao
    Chenzhou Wu
    Chenglin Wang
    Ling Ye
    Signal Transduction and Targeted Therapy, 6
  • [48] Wnt/β-catenin signaling in cancers and targeted therapies
    Yu, Fanyuan
    Yu, Changhao
    Li, Feifei
    Zuo, Yanqin
    Wang, Yitian
    Yao, Lin
    Wu, Chenzhou
    Wang, Chenglin
    Ye, Ling
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [49] Site-directed mutagenesis of putative PKC and MAPK consensus sites in the transcription factor RTEF-1 targeted by α-1 adrenergic signaling.
    Ueyama, T
    Suzow, JG
    Valenzuela, YM
    Stewart, AFR
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 75A - 75A
  • [50] MET in glioma: signaling pathways and targeted therapies
    Fangling Cheng
    Dongsheng Guo
    Journal of Experimental & Clinical Cancer Research, 38
12345